Skip to main content
Official Logo of Columbia Business School
Academic Programs
  • Visit Academic Programs
  • MBA
  • Executive MBA
  • Master of Science
  • PhD
  • Undergraduate Concentration
Faculty & Research
  • Visit Faculty & Research
  • Academic Divisions
  • Faculty Search
  • CBS Research
  • Research Resources
  • Research Opportunities
Executive Education
  • Visit Executive Education
  • For Organizations
  • For Individuals
  • Program Finder
  • Online Programs
  • Certificates
Alumni
  • Visit Alumni
  • Alumni Clubs
  • Alumni Benefits
  • Alumni Events
  • Lifetime Network
  • Women's Circle
  • Career Management
About Us
  • Visit About Us
  • The CBS Experience
  • Leadership
  • Our History
  • CBS Directory
  • Newsroom
  • Magazine
CBS Insights
  • Visit CBS Insights
  • AI & Business Analytics
  • Business & Society
  • Climate
  • Finance
  • Entrepreneurship
  • More on CBS Insights

Breadcrumb

  1. Directory
  2. Faculty
  3. Frank Lichtenberg

Frank Lichtenberg

Cain Brothers & Company Professor of Healthcare Management in the Faculty of Business
Economics Division
Cain Brothers & Company Professor of Healthcare Management in the Faculty of Business
Healthcare and Pharmaceutical Management Program
Photo of Professor Frank R. Lichtenberg
Areas of Expertise
Healthcare, Macroeconomics, Microeconomics
Contact
Office: 522 Kravis
E-mail: [email protected]
Links
Personal Website
Curriculum Vitae

Frank R. Lichtenberg is Cain Brothers & Company Professor of Healthcare Management in the Faculty of Business Economics at the Columbia University Graduate School of Business; a Research Associate of the National Bureau of Economic Research; and a member of the CESifo Research Network. He received a BA with Honors in History from the University of Chicago and an MA and PhD in Economics from the University of Pennsylvania.

Mr. Lichtenberg previously taught at Harvard University, the University of Pennsylvania, and Ecole Polytechnique. He has served as an expert for the Federal Trade Commission, the U.S. Dept. of Justice, and state Attorneys General, and has testified before Congress. He has worked for several U.S. government agencies, including the Department of Justice, the Congressional Budget Office, and the Census Bureau, and been a visiting scholar at the Wissenschaftszentrum Berlin, the University of Munich, and elsewhere.

Some of Professor Lichtenberg’s research has examined how the introduction of new technology arising from research and development affects the productivity of companies, industries and nations. He has performed studies of the impact of pharmaceutical innovation on longevity, the effect of computers on productivity in business and government organizations, and the consequences of takeovers and leveraged buyouts for efficiency and employment. His articles have been published in numerous scholarly journals and in the popular press. His book Corporate Takeovers and Productivity has been published by MIT Press.

He was awarded the 1998 Schumpeter Prize for his paper, Pharmaceutical Innovation as a Process of Creative Destruction; the 2003 Milken Institute Award for Distinguished Economic Research for the paper, Pharmaceutical Knowledge-Capital Accumulation and Longevity; and Research!America’s 2010 Garfield Economic Impact Award for the paper, The effect of new cancer drug approvals on the life expectancy of American cancer patients, 1978-2004.

He has been awarded research fellowships, grants, and contracts by the National Science Foundation, the World Health Organization, the National Institute of Standards and Technology, Merck and Co., the Fulbright Commission, the Brookings Institution, the Alfred P. Sloan Foundation, The German Marshall Fund, the American Enterprise Institute, and other organizations. He has served as a consultant to private organizations and government agencies including the Securities Industry Association, Pfizer, Inc., the Community Preservation Corporation, the RAND Corporation, the New York City Water Board, Touche Ross and Co., The Walt Disney Company, McGraw-Hill, and the National Pharmaceutical Council. He is an affiliate of the economics consulting firm Analysis Group.

Education
BA, University of Chicago, 1973; MA, University of Pennsylvania, 1976; PhD, 1982
Joined CBS
1983

All Activities

  • Research
  • Teaching
  • Awards and Honors
  • Press
  • Journal articles
  • Working papers
  • Articles
  • Books
  • Chapters
Type
Journal Article
Lichtenberg, Frank
. “Availability of New Drugs and Americans' Ability to Work.”
Journal of Occupational and Environmental Medicine
(Forthcoming).
Read More about Availability of New Drugs and Americans' Ability to Work
Download PDF on Availability of New Drugs and Americans' Ability to Work
Type
Journal Article
Lichtenberg, Frank
. “The contribution of pharmaceutical innovation to longevity growth in Germany and France, 2001–2007.”
PharmacoEconomics
vol.
30
, (March 01, 2012):
197
-
211
.
Read More about The contribution of pharmaceutical innovation to longevity growth in Germany and France, 2001–2007
Download PDF on The contribution of pharmaceutical innovation to longevity growth in Germany and France, 2001–2007
Type
Journal Article
Lichtenberg, Frank
. “Has Pharmaceutical Innovation Reduced Social Security Disability Growth?”
International Journal of the Economics of Business
vol.
18
, (July 01, 2011):
293
-
316
.
Read More about Has Pharmaceutical Innovation Reduced Social Security Disability Growth?
Download PDF on Has Pharmaceutical Innovation Reduced Social Security Disability Growth?
Type
Journal Article
Lichtenberg, Frank
. “Despite steep costs, payments for new cancer drugs make economic sense.”
Nature Medicine
vol.
17
, (March 07, 2011):
244
.
Read More about Despite steep costs, payments for new cancer drugs make economic sense
Download PDF on Despite steep costs, payments for new cancer drugs make economic sense
Type
Journal Article
Lichtenberg, Frank
. “The quality of medical care, behavioral risk factors, and longevity growth.”
International Journal of Health Care Finance and Economics
vol.
11
, (March 01, 2011):
1
-
34
.
Read More about The quality of medical care, behavioral risk factors, and longevity growth
Type
Journal Article
Lichtenberg, Frank and Bhaven Sampat
. “What Are the Respective Roles of the Public and Private Sectors in Pharmaceutical Innovation?”
Health Affairs
vol.
30
, (February 15, 2011):
332
-
339
.
Read More about What Are the Respective Roles of the Public and Private Sectors in Pharmaceutical Innovation?
Type
Journal Article
Lichtenberg, Frank
. “Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer? A Reexamination Using Data from the U.S. and Australia.”
Forum for Health Economics & Policy
vol.
13
, (May 21, 2010):
Article 11
.
Read More about Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer? A Reexamination Using Data from the U.S. and Australia
Download PDF on Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer? A Reexamination Using Data from the U.S. and Australia
Type
Journal Article
Lichtenberg, Frank
. “Pharmaceutical innovation and mortality in the United States, 1960–2000. A commentary on Schnittker and Karandinos.”
Social Science and Medicine
vol.
70
, (February 12, 2010):
969
-
971
.
Read More about Pharmaceutical innovation and mortality in the United States, 1960–2000. A commentary on Schnittker and Karandinos
Type
Journal Article
Lichtenberg, Frank
. “Pharmaceutical Price Discrimination and Social Welfare.”
Capitalism and Society
vol.
5
, (January 01, 2010):
Article 2
.
Read More about Pharmaceutical Price Discrimination and Social Welfare
Download PDF on Pharmaceutical Price Discrimination and Social Welfare
Type
Journal Article
Lichtenberg, Frank
. “The effect of drug vintage on survival: Micro evidence from Puerto Rico's Medicaid program.”
Advances in health economics and health services research
vol.
22
, (January 01, 2010):
273
-
292
.
Read More about The effect of drug vintage on survival: Micro evidence from Puerto Rico's Medicaid program
Download PDF on The effect of drug vintage on survival: Micro evidence from Puerto Rico's Medicaid program
Type
Journal Article
Lichtenberg, Frank
. “The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982-2001.”
International Journal of Health Care Finance and Economics
vol.
5
, (January 01, 2005):
47
-
73
.
Read More about The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982-2001
Download PDF on The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982-2001
Type
Journal Article
Lichtenberg, Frank
. “The Effects of Medicare on Health Care Utilization and Outcomes.”
Frontiers in Health Policy Research
vol.
5
, (January 01, 2002):
27
-
52
.
Read More about The Effects of Medicare on Health Care Utilization and Outcomes
Download PDF on The Effects of Medicare on Health Care Utilization and Outcomes
Type
Journal Article
Lichtenberg, Frank
. “Do (More and Better) Drugs Keep People Out of Hospitals?”
American Economic Review
vol.
86
, (May 01, 1996):
384
-
88
.
Read More about Do (More and Better) Drugs Keep People Out of Hospitals?
Download PDF on Do (More and Better) Drugs Keep People Out of Hospitals?
Type
Journal Article
Lichtenberg, Frank
. “The Private R and D Investment Response to Federal Design and Technical Competitions.”
American Economic Review
vol.
78
, (June 01, 1988):
550
-
59
.
Read More about The Private R and D Investment Response to Federal Design and Technical Competitions
Download PDF on The Private R and D Investment Response to Federal Design and Technical Competitions
Type
Journal Article
Bartel, Ann and Frank Lichtenberg
. “The Comparative Advantage of Educated Workers in Implementing New Technology.”
Review of Economics and Statistics
vol.
69
, (February 01, 1987):
1
-
11
.
Read More about The Comparative Advantage of Educated Workers in Implementing New Technology
Download PDF on The Comparative Advantage of Educated Workers in Implementing New Technology
Type
Working Paper
Lichtenberg, Frank
. The Impact of Biomedical Knowledge Accumulation on Mortality: A Bibliometric Analysis of Cancer Data. October 01, 2013.
Read More about The Impact of Biomedical Knowledge Accumulation on Mortality: A Bibliometric Analysis of Cancer Data
Download PDF on The Impact of Biomedical Knowledge Accumulation on Mortality: A Bibliometric Analysis of Cancer Data
Type
Working Paper
Lichtenberg, Frank
. The Impact of New (Orphan) Drug Approvals on Premature Mortality from Rare Diseases in the U.S. and France, 1999–2007. January 10, 2011.
Read More about The Impact of New (Orphan) Drug Approvals on Premature Mortality from Rare Diseases in the U.S. and France, 1999–2007
Download PDF on The Impact of New (Orphan) Drug Approvals on Premature Mortality from Rare Diseases in the U.S. and France, 1999–2007
Type
Working Paper
Lichtenberg, Frank
. Has medical innovation reduced cancer mortality? November 30, 2010.
Read More about Has medical innovation reduced cancer mortality?
Download PDF on Has medical innovation reduced cancer mortality?
Type
Working Paper
Lichtenberg, Frank
. Is Home Health Care a Substitute for Hospital Care? October 28, 2010.
Read More about Is Home Health Care a Substitute for Hospital Care?
Download PDF on Is Home Health Care a Substitute for Hospital Care?
Type
Working Paper
Lichtenberg, Frank
. The impact of medical knowledge accumulation and diffusion on health: Evidence from Medline and other N.I.H. data. May 27, 2010.
Read More about The impact of medical knowledge accumulation and diffusion on health: Evidence from Medline and other N.I.H. data
Download PDF on The impact of medical knowledge accumulation and diffusion on health: Evidence from Medline and other N.I.H. data
Type
Working Paper
Lichtenberg, Frank
. The Quality of Medical Care, Behavioral Risk Factors, and Longevity Growth. June 01, 2009.
Read More about The Quality of Medical Care, Behavioral Risk Factors, and Longevity Growth
Download PDF on The Quality of Medical Care, Behavioral Risk Factors, and Longevity Growth
Type
Working Paper
Lichtenberg, Frank and Suchin Virabhak
. Pharmaceutical-Embodied Technical Progress, Longevity, and Quality of Life: Drugs as 'Equipment for Your Health'. January 01, 2005.
Read More about Pharmaceutical-Embodied Technical Progress, Longevity, and Quality of Life: Drugs as 'Equipment for Your Health'
Type
Working Paper
Lichtenberg, Frank
. The Effect of Changes in Drug Utilization on Labor Supply and Per Capita Output. January 01, 2005.
Read More about The Effect of Changes in Drug Utilization on Labor Supply and Per Capita Output
Type
Working Paper
Lichtenberg, Frank
. The Expanding Pharmaceutical Arsenal in the War on Cancer. January 01, 2005.
Read More about The Expanding Pharmaceutical Arsenal in the War on Cancer
Download PDF on The Expanding Pharmaceutical Arsenal in the War on Cancer
Type
Working Paper
Lichtenberg, Frank
. The Dual Effects of Intellectual Property Regulations: Within- and Between-Patent Competition in the U.S. Pharmaceuticals Industry. January 01, 2005.
Read More about The Dual Effects of Intellectual Property Regulations: Within- and Between-Patent Competition in the U.S. Pharmaceuticals Industry
Type
Working Paper
Lichtenberg, Frank
. Benefits and Costs of Newer Drugs: An Update. January 01, 2005.
Read More about Benefits and Costs of Newer Drugs: An Update
Type
Working Paper
Lleras-Muney, Adriana and Frank Lichtenberg
. The Effect of Education on Medical Technology Adoption: Are the More Educated More Likely to Use New Drugs? January 01, 2005.
Read More about The Effect of Education on Medical Technology Adoption: Are the More Educated More Likely to Use New Drugs?
Type
Working Paper
Lichtenberg, Frank
. Sources of U.S. Longevity Increase, 1960-1997. January 01, 2005.
Read More about Sources of U.S. Longevity Increase, 1960-1997
Type
Working Paper
Lichtenberg, Frank
. The Impact of New Drug Launches on Longevity: From 52 Countries, 1982-2001. January 01, 2005.
Read More about The Impact of New Drug Launches on Longevity: From 52 Countries, 1982-2001
Type
Working Paper
Lichtenberg, Frank
. The Effect of New Drugs on Mortality from Rare Diseases and HIV. May 01, 2002.
Read More about The Effect of New Drugs on Mortality from Rare Diseases and HIV
Type
Working Paper
Lichtenberg, Frank
. The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey. January 01, 2001.
Read More about The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey
Type
Working Paper
Lichtenberg, Frank
. Pharmaceutical Innovation, Mortality Reduction, and Economic Growth. May 01, 1998.
Read More about Pharmaceutical Innovation, Mortality Reduction, and Economic Growth
Type
Working Paper
Lichtenberg, Frank
. The Allocation of Publicly-Funded Biomedical Research. January 01, 1998.
Read More about The Allocation of Publicly-Funded Biomedical Research
Type
Working Paper
Lichtenberg, Frank
. The Effect of Pharmaceutical Utilization and Innovation on Hospitalization and Mortality. January 01, 1996.
Read More about The Effect of Pharmaceutical Utilization and Innovation on Hospitalization and Mortality
Type
Newspaper/Magazine Article
Lichtenberg, Frank
. “Importation and Innovation.”
Chazen Web Journal of International Business
. January 01, 2005.
Read More about Importation and Innovation
Download PDF on Importation and Innovation
Type
Newspaper/Magazine Article
Lichtenberg, Frank
. “Pharmaceutical Innovation and the Burden of Disease in Developing and Developed Countries.”
Chazen Web Journal of International Business
. January 01, 2005.
Read More about Pharmaceutical Innovation and the Burden of Disease in Developing and Developed Countries
Download PDF on Pharmaceutical Innovation and the Burden of Disease in Developing and Developed Countries
Type
Book
Lichtenberg, Frank
. Corporate Takeovers and Productivity. 
Cambridge, Mass.
:
MIT Press
, 1992.
Read More about Corporate Takeovers and Productivity
Type
Chapter
Lichtenberg, Frank
. “Pharmaceutical Knowledge-Capital Accumulation and Longevity.” In
Measuring Capital in the New Economy
, edited by
Carol Corrado, John Haltiwanger, and Daniel Sichel
,
Chicago
:
University of Chicago Press
, 2005.
Read More about Pharmaceutical Knowledge-Capital Accumulation and Longevity
Download PDF on Pharmaceutical Knowledge-Capital Accumulation and Longevity
  • Courses
  • Case Studies
Type
Course
B8221: Economics of Healthcare and Pharmaceuticals
View Course on Economics of Healthcare and Pharmaceuticals
Type
Course
B6200: Managerial Economics
View Course on Managerial Economics
Type
Course
B5200: Managerial Economics
View Course on Managerial Economics
  • Awards & Honors
  • In the Media
  • Ideas
  • Research In Brief
  • Press Releases
Type
In the Media

Delta Air Lines' Raising Insurance Rates for Unvaccinated Makes Dense - and It's a Scary Idea

The Los Angeles Times
Type
In the Media

Creating a Covid-19 Vaccine Is Only the First Step. Reaching the World Is the Next.

NBC News
Type
In the Media

How Much Could Pfizer Make from a COVID-19 Vaccine?

Marketplace
Type
In the Media

Why You Should Take Coronavirus Vaccine News with a Grain of Salt

Salon
Type
In the Media

Wave of 'Vaccine Nationalism' Hinders Global Efforts to Halt Coronavirus

NBC News
Type
In the Media

Democrats Tout Federal Patent Take-Backs for Lowering Drug Costs

Bloomberg News
Official Logo of Columbia Business School

Columbia University in the City of New York
665 West 130th Street, New York, NY 10027
Tel. 212-854-1100

Maps and Directions
    • Centers & Programs
    • Current Students
    • Corporate
    • Directory
    • Support Us
    • Recruiters & Partners
    • Faculty & Staff
    • Newsroom
    • Careers
    • Contact Us
    • Privacy & Policy Statements
Back to Top Upward arrow
TOP

© Columbia University

  • Twitter
  • Instagram
  • Facebook
  • YouTube
  • LinkedIn